Arthur, Would not get to carried away with NTA on these type of stocks.
A pile of cash without an income and profit generating business model attached is meaningless.
Don't get me wrong I believe SIE is a biotech to watch but guard against making entry decisions on NTA for any stock other than one's that have established income streams.
NTA for a bluechip is worth hell of a lot more than NTA for a spec.
In this market to consider entering anything other than a goldie for a long term hold is a ballsy move.
BTW the Kiwi's are through top and middle order.
Rob.
entry price., page-6
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)